Align Technology Announces $200 Million Accelerated Stock Repurchase Program Joe Hogan, president and CEO, intends to personally purchase $2.0 million of Align’s common stock TEMPE, Ariz., May 02, 2022 (GLOBE NEWSWIRE) -- Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it has entered into a new accelerated stock repurchase agreement ("ASR") with...
Align Technology Announces First Quarter 2022 Financial Results Commemorates 25 years of smiles and innovation through doctor-directed care with major milestones including 217K Invisalign trained doctors, 12.8M Invisalign patients, 73K iTero scanners, and 49K exocad software licenses Q1'22 total revenues of $973.2 million, compared to $894.8 million in Q1'21Q1'22 Invisalign volume of 598.8 thousand cases, compared to 595.8 thousand cases in Q1'21Q1'22 Invisalign cases for teenage patients of 175.2 thousand cases, 29.3% of total volumes, compared to 165.3 thousand cases, or 27.7% of total ...
Align Technology to Announce First Quarter 2022 Results on April 27, 2022 TEMPE, Ariz., April 05, 2022 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report first quarter 2022 financial results on Wednesday, April 27, 2022, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be a...
Citigroup (C) looks to finally be rounding the corner of its transformational reconstruction. Uniform Accounting shows both the company's significant operational improvements, and that the market isn't pricing them in sustainably. That makes Citi a compelling buy. Citi has historically been a worst-in-class performer in terms of Uniform ROE, around 5% in the early 2010s, however, these operational improvements have already lifted ROE towards peer levels, approaching double-digit levels, and the...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.